We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
New drugs for breast cancer, leukemia, hepatitis B and myelofibrosis may be available to European patients soon, as the European Medicines Agency’s Committee for Medicinal Products for Human Use (EMA/CHMP) recommended that the agency approve 15 new drugs, including two biosimilars and four generics, at its Dec. 7-10 meeting. Read More
A coalition of hospital groups has filed a lawsuit alleging that HHS failed to ensure that drugmakers offer discounted medications to covered entity hospitals under the 340 drug discount program. Read More
Supported by promising phase 1 data, CureVac announced Monday that it has enrolled the first participant in the pivotal phase 2b/3 study of its messenger-RNA based coronavirus vaccine, CVnCoV. Read More
Researchers with the UK’s multi-armed RECOVERY trial have determined that the widely used antibiotic azithromycin was not beneficial for patients hospitalized with COVID-19 and are discontinuing their evaluation of the drug. Read More
Canada administered its first shots of Pfizer/BioNTech’s COVID-19 vaccine to frontline healthcare workers Monday as coronavirus vaccinations also got underway in the U.S. Read More
Boehringer Ingelheim (BI) is acquiring NBE-Therapeutics for $1.5 billion, adding to its cancer portfolio with novel antibody-drug conjugates (ADC). Read More